ÂÜÀòÂÒÂ×

Nathan Franklin is an experienced Senior Scientist II at Oxford Biomedica since April 2018, focused on advancing manufacturing processes for lentivirus-based therapies and fostering automation to enhance laboratory workflow. With a strong background in analytical support for drug candidates and leadership in project coordination and staff management, Nathan has achieved significant milestones, including timely GMP-scale production and stability trial reports. Previous roles at GeneFirst Ltd and Enigma Diagnostics Limited involved integral contributions to molecular diagnostics and point-of-care systems, showcasing a consistent trajectory of scientific excellence and innovation. Nathan holds a BSc (Hons) in Biochemistry from Lancaster University.